

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil migration (GO:0072677) | 9.73335406 |
| 2 | regulation of sister chromatid cohesion (GO:0007063) | 9.66226279 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 9.57353569 |
| 4 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 9.53891311 |
| 5 | branch elongation of an epithelium (GO:0060602) | 8.52419921 |
| 6 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 8.04591913 |
| 7 | positive regulation of chromosome segregation (GO:0051984) | 7.96488813 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 7.77273536 |
| 9 | L-fucose catabolic process (GO:0042355) | 7.75946616 |
| 10 | fucose catabolic process (GO:0019317) | 7.75946616 |
| 11 | L-fucose metabolic process (GO:0042354) | 7.75946616 |
| 12 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 7.73654979 |
| 13 | vesicle fusion (GO:0006906) | 7.69111648 |
| 14 | peptidyl-lysine dimethylation (GO:0018027) | 7.39622632 |
| 15 | coenzyme A biosynthetic process (GO:0015937) | 7.11775319 |
| 16 | autophagic vacuole fusion (GO:0000046) | 6.92483130 |
| 17 | macrophage chemotaxis (GO:0048246) | 6.83481310 |
| 18 | organ growth (GO:0035265) | 6.58207254 |
| 19 | localization within membrane (GO:0051668) | 6.51977958 |
| 20 | axis elongation (GO:0003401) | 6.37644085 |
| 21 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 5.98248932 |
| 22 | regulation of beta-amyloid formation (GO:1902003) | 5.93381134 |
| 23 | positive regulation of calcium ion import (GO:0090280) | 5.92674995 |
| 24 | establishment of mitotic spindle orientation (GO:0000132) | 5.92092798 |
| 25 | negative regulation of GTPase activity (GO:0034260) | 5.76760500 |
| 26 | negative regulation of GTP catabolic process (GO:0033125) | 5.76760500 |
| 27 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.75611603 |
| 28 | monocyte chemotaxis (GO:0002548) | 5.72141491 |
| 29 | protein import into peroxisome matrix (GO:0016558) | 5.42824654 |
| 30 | organelle membrane fusion (GO:0090174) | 5.42404356 |
| 31 | double-strand break repair via nonhomologous end joining (GO:0006303) | 5.23998208 |
| 32 | non-recombinational repair (GO:0000726) | 5.23998208 |
| 33 | establishment of mitotic spindle localization (GO:0040001) | 5.22784271 |
| 34 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 5.17330832 |
| 35 | establishment of spindle orientation (GO:0051294) | 5.14317594 |
| 36 | acrosome assembly (GO:0001675) | 4.90888732 |
| 37 | negative regulation of circadian rhythm (GO:0042754) | 4.90633386 |
| 38 | histone H3-K9 methylation (GO:0051567) | 4.82870953 |
| 39 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.79424042 |
| 40 | positive chemotaxis (GO:0050918) | 4.74106730 |
| 41 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.69902545 |
| 42 | regulation of autophagic vacuole assembly (GO:2000785) | 4.67552727 |
| 43 | seminiferous tubule development (GO:0072520) | 4.66251929 |
| 44 | pantothenate metabolic process (GO:0015939) | 4.61936261 |
| 45 | organelle fusion (GO:0048284) | 4.60373777 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.55462946 |
| 47 | oxidative demethylation (GO:0070989) | 4.54309485 |
| 48 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.46525847 |
| 49 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.46525847 |
| 50 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.46525847 |
| 51 | regulation of stem cell maintenance (GO:2000036) | 4.43320800 |
| 52 | fucose metabolic process (GO:0006004) | 4.37522822 |
| 53 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.32609951 |
| 54 | membrane budding (GO:0006900) | 4.29003909 |
| 55 | protein targeting to lysosome (GO:0006622) | 4.13143589 |
| 56 | establishment of protein localization to vacuole (GO:0072666) | 4.13143589 |
| 57 | protein targeting to vacuole (GO:0006623) | 4.13143589 |
| 58 | coenzyme A metabolic process (GO:0015936) | 4.11407339 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.09314842 |
| 60 | fucosylation (GO:0036065) | 4.06972809 |
| 61 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 4.02943695 |
| 62 | histone H3-K9 modification (GO:0061647) | 4.01265746 |
| 63 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 4.01261218 |
| 64 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 4.00097064 |
| 65 | negative regulation of macroautophagy (GO:0016242) | 3.90021615 |
| 66 | regulation of vacuole organization (GO:0044088) | 3.89323761 |
| 67 | regulation of cellular amide metabolic process (GO:0034248) | 3.84082969 |
| 68 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.83446752 |
| 69 | single-organism membrane fusion (GO:0044801) | 3.80233797 |
| 70 | establishment of spindle localization (GO:0051293) | 3.79393714 |
| 71 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.78987066 |
| 72 | negative regulation of nucleoside metabolic process (GO:0045978) | 3.63051550 |
| 73 | vesicle targeting (GO:0006903) | 3.58975632 |
| 74 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.58820930 |
| 75 | protein localization to peroxisome (GO:0072662) | 3.56385237 |
| 76 | protein targeting to peroxisome (GO:0006625) | 3.56385237 |
| 77 | establishment of protein localization to peroxisome (GO:0072663) | 3.56385237 |
| 78 | DNA integration (GO:0015074) | 3.55795804 |
| 79 | regulation of calcium ion import (GO:0090279) | 3.55750953 |
| 80 | sodium-independent organic anion transport (GO:0043252) | 3.48520319 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 3.46255514 |
| 82 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.42626993 |
| 83 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39295778 |
| 84 | labyrinthine layer development (GO:0060711) | 3.34059191 |
| 85 | peroxisomal transport (GO:0043574) | 3.32348237 |
| 86 | telomere maintenance via recombination (GO:0000722) | 3.30019318 |
| 87 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.29480237 |
| 88 | Golgi transport vesicle coating (GO:0048200) | 3.28086379 |
| 89 | COPI coating of Golgi vesicle (GO:0048205) | 3.28086379 |
| 90 | protein localization to vacuole (GO:0072665) | 3.27886471 |
| 91 | protein localization to lysosome (GO:0061462) | 3.27886471 |
| 92 | peptidyl-lysine trimethylation (GO:0018023) | 3.23391528 |
| 93 | prenylation (GO:0097354) | 12.7078589 |
| 94 | protein prenylation (GO:0018342) | 12.7078589 |
| 95 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 12.3915894 |
| 96 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 12.3915894 |
| 97 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 12.3915894 |
| 98 | negative regulation of Ras GTPase activity (GO:0034261) | 12.2202608 |
| 99 | eosinophil chemotaxis (GO:0048245) | 10.7536927 |
| 100 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 10.3044694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 9.04973218 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 6.15052831 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.71650899 |
| 4 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 4.52015024 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.47661806 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.92948942 |
| 7 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.70210727 |
| 8 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.66157933 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.60905828 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.37675250 |
| 11 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.37547321 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.31245179 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29306888 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 11.6349316 |
| 15 | RXR_22108803_ChIP-Seq_LS180_Human | 1.94767399 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94068949 |
| 17 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.89636796 |
| 18 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.85219233 |
| 19 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85219233 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.59313909 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57211063 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52128701 |
| 23 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.45890458 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44828170 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.43684395 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.43684395 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.43684395 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38337730 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.33246723 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29701883 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28154005 |
| 32 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.24008263 |
| 33 | GATA3_26560356_Chip-Seq_TH1_Human | 1.23572995 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20039397 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17069138 |
| 36 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16062764 |
| 37 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13679388 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13381858 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12756087 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11519722 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07489622 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03540656 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03328066 |
| 44 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98153961 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95863037 |
| 46 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.94840057 |
| 47 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94006132 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91328945 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90833331 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90535055 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.88210279 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87155690 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84277497 |
| 54 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84120620 |
| 55 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.82175598 |
| 56 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.81906731 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81846769 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80578988 |
| 59 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.78344555 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77482922 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75661104 |
| 62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73799884 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.71697378 |
| 64 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.69270054 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.67836508 |
| 66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67616418 |
| 67 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.65798261 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.64698215 |
| 69 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.64251823 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62258617 |
| 71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61640864 |
| 72 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.61635673 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.60741852 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60738591 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.59190299 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.58748692 |
| 77 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.58242220 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.58208661 |
| 79 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.58146970 |
| 80 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.58048221 |
| 81 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.58011925 |
| 82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.57207186 |
| 83 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.56685144 |
| 84 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.56024092 |
| 85 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.55988930 |
| 86 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.54539565 |
| 87 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.54257769 |
| 88 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.53283369 |
| 89 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53173194 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52980430 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.52637028 |
| 92 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.52366759 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.52158863 |
| 94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.51432201 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.51355730 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.50951807 |
| 97 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.50951807 |
| 98 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.50873190 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.50413346 |
| 100 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.50201621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 9.97994437 |
| 2 | MP0006082_CNS_inflammation | 5.48455226 |
| 3 | MP0000467_abnormal_esophagus_morphology | 3.33206971 |
| 4 | MP0001664_abnormal_digestion | 3.23751680 |
| 5 | MP0001663_abnormal_digestive_system | 3.14774787 |
| 6 | MP0001919_abnormal_reproductive_system | 2.77723736 |
| 7 | MP0002751_abnormal_autonomic_nervous | 2.56916003 |
| 8 | MP0000383_abnormal_hair_follicle | 2.48929299 |
| 9 | MP0003115_abnormal_respiratory_system | 2.47548205 |
| 10 | MP0005381_digestive/alimentary_phenotyp | 2.44629901 |
| 11 | MP0000566_synostosis | 13.0429020 |
| 12 | MP0005166_decreased_susceptibility_to | 1.86259665 |
| 13 | MP0002876_abnormal_thyroid_physiology | 1.77574419 |
| 14 | MP0010678_abnormal_skin_adnexa | 1.72505618 |
| 15 | MP0005389_reproductive_system_phenotype | 1.62337846 |
| 16 | MP0001915_intracranial_hemorrhage | 1.60638942 |
| 17 | MP0000534_abnormal_ureter_morphology | 1.60414995 |
| 18 | MP0003453_abnormal_keratinocyte_physiol | 1.60131186 |
| 19 | MP0003937_abnormal_limbs/digits/tail_de | 1.55625761 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 1.43848665 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.43848665 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.43460869 |
| 23 | MP0000428_abnormal_craniofacial_morphol | 1.40512132 |
| 24 | MP0005501_abnormal_skin_physiology | 1.12991493 |
| 25 | MP0000858_altered_metastatic_potential | 1.10567240 |
| 26 | MP0001286_abnormal_eye_development | 1.09782509 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.06152829 |
| 28 | MP0000490_abnormal_crypts_of | 1.05226955 |
| 29 | MP0001293_anophthalmia | 1.02710008 |
| 30 | MP0002019_abnormal_tumor_incidence | 0.95500067 |
| 31 | MP0001764_abnormal_homeostasis | 0.88871736 |
| 32 | MP0003329_amyloid_beta_deposits | 0.85305818 |
| 33 | MP0002109_abnormal_limb_morphology | 0.84420454 |
| 34 | MP0000470_abnormal_stomach_morphology | 0.84413757 |
| 35 | MP0003942_abnormal_urinary_system | 0.81055476 |
| 36 | MP0002115_abnormal_skeleton_extremities | 0.78642811 |
| 37 | MP0005197_abnormal_uvea_morphology | 0.77579375 |
| 38 | MP0010155_abnormal_intestine_physiology | 0.76933287 |
| 39 | MP0000026_abnormal_inner_ear | 0.76644798 |
| 40 | MP0001963_abnormal_hearing_physiology | 0.72684497 |
| 41 | MP0000358_abnormal_cell_content/ | 0.72135903 |
| 42 | MP0009763_increased_sensitivity_to | 0.68974411 |
| 43 | MP0005508_abnormal_skeleton_morphology | 0.65641761 |
| 44 | MP0000477_abnormal_intestine_morphology | 0.64053546 |
| 45 | MP0002405_respiratory_system_inflammati | 0.60326686 |
| 46 | MP0000432_abnormal_head_morphology | 0.57757014 |
| 47 | MP0005023_abnormal_wound_healing | 0.55918984 |
| 48 | MP0002184_abnormal_innervation | 0.54818339 |
| 49 | MP0000604_amyloidosis | 0.54712227 |
| 50 | MP0009672_abnormal_birth_weight | 0.52174952 |
| 51 | MP0001175_abnormal_lung_morphology | 0.51810950 |
| 52 | MP0000681_abnormal_thyroid_gland | 0.50343950 |
| 53 | MP0002113_abnormal_skeleton_development | 0.48459283 |
| 54 | MP0003935_abnormal_craniofacial_develop | 0.48371947 |
| 55 | MP0002210_abnormal_sex_determination | 0.47467101 |
| 56 | MP0002168_other_aberrant_phenotype | 0.46867358 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 0.46785382 |
| 58 | MP0003448_altered_tumor_morphology | 0.45711049 |
| 59 | MP0000377_abnormal_hair_follicle | 0.44645767 |
| 60 | MP0005025_abnormal_response_to | 0.43893512 |
| 61 | MP0005253_abnormal_eye_physiology | 0.41804410 |
| 62 | MP0002822_catalepsy | 0.40260897 |
| 63 | MP0005423_abnormal_somatic_nervous | 0.40066467 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.38747741 |
| 65 | MP0000627_abnormal_mammary_gland | 0.36951503 |
| 66 | MP0000163_abnormal_cartilage_morphology | 0.36380946 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.32944391 |
| 68 | MP0002697_abnormal_eye_size | 0.32783381 |
| 69 | MP0005391_vision/eye_phenotype | 0.32773787 |
| 70 | MP0003936_abnormal_reproductive_system | 0.32274690 |
| 71 | MP0002452_abnormal_antigen_presenting | 0.32174203 |
| 72 | MP0003880_abnormal_central_pattern | 0.31972711 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.31765133 |
| 74 | MP0008004_abnormal_stomach_pH | 0.29542482 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.29482453 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.29260023 |
| 77 | MP0005390_skeleton_phenotype | 0.28310344 |
| 78 | MP0003195_calcinosis | 0.27024947 |
| 79 | MP0002735_abnormal_chemical_nociception | 0.26753438 |
| 80 | MP0001800_abnormal_humoral_immune | 0.26178649 |
| 81 | MP0010771_integument_phenotype | 0.25987720 |
| 82 | MP0008058_abnormal_DNA_repair | 0.24416036 |
| 83 | MP0003646_muscle_fatigue | 0.24008283 |
| 84 | MP0002736_abnormal_nociception_after | 0.20184477 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.19879048 |
| 86 | MP0004197_abnormal_fetal_growth/weight/ | 0.19267533 |
| 87 | MP0000350_abnormal_cell_proliferation | 0.19192971 |
| 88 | MP0001819_abnormal_immune_cell | 0.19087485 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.18002440 |
| 90 | MP0009931_abnormal_skin_appearance | 0.17891846 |
| 91 | MP0000049_abnormal_middle_ear | 0.17032429 |
| 92 | MP0005275_abnormal_skin_tensile | 0.16873867 |
| 93 | MP0005332_abnormal_amino_acid | 0.16798369 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.16078667 |
| 95 | MP0002419_abnormal_innate_immunity | 0.15943352 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.15942988 |
| 97 | MP0005671_abnormal_response_to | 0.15899678 |
| 98 | MP0003283_abnormal_digestive_organ | 0.15462683 |
| 99 | MP0000343_altered_response_to | 0.15460841 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.15442693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Duplicated collecting system (HP:0000081) | 9.32672066 |
| 2 | Long foot (HP:0001833) | 9.10659879 |
| 3 | Abnormality of the renal collecting system (HP:0004742) | 8.40649899 |
| 4 | Large for gestational age (HP:0001520) | 7.13686601 |
| 5 | Acute lymphatic leukemia (HP:0006721) | 7.09001387 |
| 6 | Progressive muscle weakness (HP:0003323) | 6.98011128 |
| 7 | Adactyly (HP:0009776) | 6.66150429 |
| 8 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.36863095 |
| 9 | Hypoplastic pelvis (HP:0008839) | 6.14312000 |
| 10 | Dry hair (HP:0011359) | 5.74547858 |
| 11 | Pulmonary artery stenosis (HP:0004415) | 5.65807712 |
| 12 | Autoamputation (HP:0001218) | 5.63791677 |
| 13 | Ureteral stenosis (HP:0000071) | 5.53249766 |
| 14 | Brushfield spots (HP:0001088) | 5.24260346 |
| 15 | Steatorrhea (HP:0002570) | 5.19461767 |
| 16 | Menstrual irregularities (HP:0000858) | 5.15923083 |
| 17 | Ureteral obstruction (HP:0006000) | 5.12851222 |
| 18 | Ureteral duplication (HP:0000073) | 5.11152785 |
| 19 | Hypoplastic nipples (HP:0002557) | 4.83802115 |
| 20 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.55392565 |
| 21 | Abnormal auditory evoked potentials (HP:0006958) | 4.48894487 |
| 22 | Sudden death (HP:0001699) | 4.47994078 |
| 23 | Abnormal ventriculo-arterial connection (HP:0011563) | 4.20457634 |
| 24 | Transposition of the great arteries (HP:0001669) | 4.20457634 |
| 25 | Abnormal connection of the cardiac segments (HP:0011545) | 4.20457634 |
| 26 | Fat malabsorption (HP:0002630) | 4.01927900 |
| 27 | Decreased lacrimation (HP:0000633) | 3.96667018 |
| 28 | Increased number of teeth (HP:0011069) | 3.92144793 |
| 29 | Severe muscular hypotonia (HP:0006829) | 3.91059167 |
| 30 | Palmoplantar hyperkeratosis (HP:0000972) | 3.83307307 |
| 31 | Anhidrosis (HP:0000970) | 3.82980619 |
| 32 | Broad-based gait (HP:0002136) | 3.78301917 |
| 33 | Palmar hyperkeratosis (HP:0010765) | 3.61633680 |
| 34 | Abnormality of vision evoked potentials (HP:0000649) | 3.40040264 |
| 35 | Polyneuropathy (HP:0001271) | 3.31445217 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.30063512 |
| 37 | Generalized amyotrophy (HP:0003700) | 3.26160929 |
| 38 | Wide intermamillary distance (HP:0006610) | 3.20632546 |
| 39 | Broad nasal tip (HP:0000455) | 3.19486081 |
| 40 | Myoglobinuria (HP:0002913) | 3.17012074 |
| 41 | Large hands (HP:0001176) | 3.13998805 |
| 42 | Plantar hyperkeratosis (HP:0007556) | 3.11030931 |
| 43 | Decreased muscle mass (HP:0003199) | 3.08799510 |
| 44 | Polymicrogyria (HP:0002126) | 3.01284785 |
| 45 | Clubbing of toes (HP:0100760) | 2.95821249 |
| 46 | Epiphyseal stippling (HP:0010655) | 2.67334005 |
| 47 | Flat face (HP:0012368) | 2.54782335 |
| 48 | Hypoplastic iliac wings (HP:0002866) | 2.53158373 |
| 49 | Chorioretinal coloboma (HP:0000567) | 2.51495025 |
| 50 | Steppage gait (HP:0003376) | 2.44775140 |
| 51 | Basal ganglia calcification (HP:0002135) | 2.43248949 |
| 52 | Purpura (HP:0000979) | 2.41821626 |
| 53 | Overfolded helix (HP:0000396) | 2.41814679 |
| 54 | Widely spaced teeth (HP:0000687) | 2.35218864 |
| 55 | Thickened calvaria (HP:0002684) | 2.29440366 |
| 56 | Posterior embryotoxon (HP:0000627) | 2.28021858 |
| 57 | Abnormality of the line of Schwalbe (HP:0008048) | 2.20936077 |
| 58 | Foot dorsiflexor weakness (HP:0009027) | 2.18328556 |
| 59 | Anxiety (HP:0000739) | 2.18001531 |
| 60 | Abnormally folded helix (HP:0008544) | 2.17999049 |
| 61 | Absent toe (HP:0010760) | 2.17299183 |
| 62 | Female pseudohermaphroditism (HP:0010458) | 2.11648120 |
| 63 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.08422471 |
| 64 | External ear malformation (HP:0008572) | 2.03335750 |
| 65 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 2.02497402 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 12.0734098 |
| 67 | Thickened nuchal skin fold (HP:0000474) | 1.99692481 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 1.98464569 |
| 69 | Hammertoe (HP:0001765) | 1.95588309 |
| 70 | Prenatal maternal abnormality (HP:0002686) | 1.94369426 |
| 71 | Primary adrenal insufficiency (HP:0008207) | 1.90876701 |
| 72 | Abnormal epiphyseal ossification (HP:0010656) | 1.89356089 |
| 73 | Generalized muscle weakness (HP:0003324) | 1.84854099 |
| 74 | Gangrene (HP:0100758) | 1.82965406 |
| 75 | Stereotypic behavior (HP:0000733) | 1.80921140 |
| 76 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.80086790 |
| 77 | Arterial thrombosis (HP:0004420) | 1.78197730 |
| 78 | Spastic tetraplegia (HP:0002510) | 1.76012491 |
| 79 | Arthrogryposis multiplex congenita (HP:0002804) | 1.72414158 |
| 80 | Congenital onset (HP:0003577) | 1.70970937 |
| 81 | Depressed nasal ridge (HP:0000457) | 1.67654109 |
| 82 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.67505446 |
| 83 | Decreased motor nerve conduction velocity (HP:0003431) | 1.64334072 |
| 84 | Nail dystrophy (HP:0008404) | 1.57715849 |
| 85 | Underdeveloped supraorbital ridges (HP:0009891) | 1.56294203 |
| 86 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.56151601 |
| 87 | Lactic acidosis (HP:0003128) | 1.55727097 |
| 88 | Short philtrum (HP:0000322) | 1.55033913 |
| 89 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.54395539 |
| 90 | Scrotal hypoplasia (HP:0000046) | 1.52941276 |
| 91 | Hyperammonemia (HP:0001987) | 1.50905303 |
| 92 | Brachycephaly (HP:0000248) | 1.50340513 |
| 93 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.48267856 |
| 94 | Hypoplastic ilia (HP:0000946) | 1.46496736 |
| 95 | Pulmonary embolism (HP:0002204) | 1.39487951 |
| 96 | Abnormality of primary teeth (HP:0006481) | 1.39335501 |
| 97 | Webbed neck (HP:0000465) | 1.36295471 |
| 98 | Opacification of the corneal stroma (HP:0007759) | 1.34703904 |
| 99 | Freckling (HP:0001480) | 1.33370570 |
| 100 | Metabolic acidosis (HP:0001942) | 1.27132672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK1 | 6.81550839 |
| 2 | TAOK2 | 5.59650995 |
| 3 | TAOK1 | 5.52979770 |
| 4 | MAP3K3 | 4.13601277 |
| 5 | MAP3K11 | 4.05809118 |
| 6 | MAP2K3 | 4.00631342 |
| 7 | JAK3 | 2.46660932 |
| 8 | MKNK2 | 11.5286131 |
| 9 | ABL2 | 1.87707337 |
| 10 | DYRK1A | 1.76007058 |
| 11 | MAP3K5 | 1.34293077 |
| 12 | MAP3K1 | 1.00988541 |
| 13 | SRPK1 | 0.95301597 |
| 14 | CHEK2 | 0.78171402 |
| 15 | MAP3K8 | 0.66594501 |
| 16 | PRKCQ | 0.47626986 |
| 17 | KDR | 0.24569880 |
| 18 | TXK | 0.22945538 |
| 19 | CSNK1A1 | 0.18700281 |
| 20 | MAP3K10 | 0.16973045 |
| 21 | ABL1 | 0.16930570 |
| 22 | IGF1R | 0.15595290 |
| 23 | INSRR | 0.14608455 |
| 24 | OBSCN | 0.14055716 |
| 25 | MUSK | 0.12782230 |
| 26 | GRK1 | 0.12545101 |
| 27 | MAP4K2 | 0.08700810 |
| 28 | PRKCD | 0.07621001 |
| 29 | GRK7 | 0.07413204 |
| 30 | WNK3 | 0.05551985 |
| 31 | CSNK2A2 | 0.05268453 |
| 32 | TIE1 | 0.04906895 |
| 33 | ADRBK2 | 0.04727530 |
| 34 | MAPK15 | 0.04576659 |
| 35 | PINK1 | 0.04224011 |
| 36 | CSNK2A1 | 0.01828465 |
| 37 | PRKCA | 0.00939476 |
| 38 | PIK3CG | 0.00442999 |
| 39 | CSNK1E | 0.00438691 |
| 40 | AURKA | 0.00271431 |
| 41 | PRKCE | -0.1210686 |
| 42 | TGFBR2 | -0.1200535 |
| 43 | PIK3CA | -0.1191349 |
| 44 | MARK1 | -0.1177029 |
| 45 | ZAK | -0.1162422 |
| 46 | CAMK2B | -0.1111318 |
| 47 | EGFR | -0.1108319 |
| 48 | PRKACG | -0.1104602 |
| 49 | PRKG1 | -0.1102734 |
| 50 | ROCK1 | -0.1082750 |
| 51 | STK39 | -0.1078711 |
| 52 | MAPK14 | -0.1077799 |
| 53 | MAPK4 | -0.1060383 |
| 54 | TNK2 | -0.1041454 |
| 55 | CAMK2G | -0.1011098 |
| 56 | CDK2 | -0.1010194 |
| 57 | MAPKAPK5 | -0.0999234 |
| 58 | PRKCG | -0.0989375 |
| 59 | WEE1 | -0.0982772 |
| 60 | MAP2K6 | -0.0973854 |
| 61 | PIM1 | -0.0945120 |
| 62 | MAP4K1 | -0.0926501 |
| 63 | PKN1 | -0.0923726 |
| 64 | WNK4 | -0.0910617 |
| 65 | CAMK2A | -0.0875911 |
| 66 | DAPK3 | -0.0875015 |
| 67 | LYN | -0.0823282 |
| 68 | SYK | -0.0804042 |
| 69 | NEK9 | -0.0797619 |
| 70 | PIM2 | -0.0786391 |
| 71 | BTK | -0.0782127 |
| 72 | OXSR1 | -0.0762499 |
| 73 | EPHA2 | -0.0748957 |
| 74 | ERBB2 | -0.0726635 |
| 75 | VRK2 | -0.0712866 |
| 76 | NTRK2 | -0.0701319 |
| 77 | VRK1 | -0.0667671 |
| 78 | ADRBK1 | -0.0633596 |
| 79 | TLK1 | -0.0609541 |
| 80 | BLK | -0.0593226 |
| 81 | DDR2 | -0.0590916 |
| 82 | FRK | -0.0585720 |
| 83 | PHKG1 | -0.0548971 |
| 84 | PHKG2 | -0.0548971 |
| 85 | LMTK2 | -0.0490713 |
| 86 | ITK | -0.0469519 |
| 87 | MST1R | -0.0455961 |
| 88 | TTN | -0.0423622 |
| 89 | PLK4 | -0.0418718 |
| 90 | EPHA4 | -0.0361392 |
| 91 | GRK6 | -0.0347717 |
| 92 | GRK5 | -0.0297027 |
| 93 | TEC | -0.0295356 |
| 94 | PRKACA | -0.0236229 |
| 95 | MYLK | -0.0200024 |
| 96 | KIT | -0.0186681 |
| 97 | SRC | -0.0178995 |
| 98 | PRKCB | -0.0166716 |
| 99 | MATK | -0.0146687 |
| 100 | ERBB4 | -0.0003731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 8.78908178 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 7.15438340 |
| 3 | Taste transduction_Homo sapiens_hsa04742 | 3.11797985 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.02158470 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.91347061 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.78187012 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.67403029 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.64761679 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.49363137 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 2.47988485 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.94612105 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.92909193 |
| 13 | Amoebiasis_Homo sapiens_hsa05146 | 1.84962181 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.77344721 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.77228151 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63777931 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58150882 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17092135 |
| 19 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.12202322 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12010536 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.08592041 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01791694 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00546753 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90194741 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79802717 |
| 26 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72184554 |
| 27 | Malaria_Homo sapiens_hsa05144 | 0.71213013 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64269058 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64113868 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64059291 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63320298 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63017817 |
| 33 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62306739 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 0.61355199 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61184455 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59918826 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59141754 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57928325 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57898515 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 0.57466851 |
| 41 | Asthma_Homo sapiens_hsa05310 | 0.57107748 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56466893 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55764557 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.53541514 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53231097 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52899390 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52072481 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.49993281 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49091501 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.49012360 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47449076 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46452484 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46079753 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45971741 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45089368 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44280092 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43038402 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40378412 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39838689 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39678134 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38130522 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36384285 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35996971 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34899787 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34875885 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34484339 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33784188 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33231906 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32442730 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.31624372 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29463802 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29111424 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.28682548 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.28603869 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27871840 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26704745 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.26024131 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25863624 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25423879 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.22519239 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21955682 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.20552188 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.19825932 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.19168937 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.18681286 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17829325 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.17382435 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16771878 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16113368 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.15755503 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.15356614 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13346966 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.13264384 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11782722 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11050973 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.10432345 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.10107705 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10069364 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.08533705 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.08491229 |

